Asia Pacific sports medicine market will grow by 9.1% annually with a total addressable market cap of $23.25 billion over 2020-2030 owing to the rising incidents of sports injuries, consistent innovation of new products and treatment modalities, and growing healthcare expenditure.
Highlighted with 39 tables and 55 figures, this 125-page report 鈥淎sia Pacific Sports Medicine 麻豆原创 2020-2030 by Product (Repair, Recovery, Monitoring, Accessories), Application (Knee, Shoulder, Hip), End User, and Country: Trend Forecast and Growth Opportunity鈥 is based on a comprehensive research of the entire Asia Pacific sports medicine market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2015-2019 and provides forecast from 2020 till 2030 with 2019 as the base year. (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)
In-depth qualitative analyses include identification and investigation of the following aspects:
鈥 麻豆原创 Structure
鈥 Growth Drivers
鈥 Restraints and Challenges
鈥 Emerging Product Trends & 麻豆原创 Opportunities
鈥 Porter鈥檚 Fiver Forces
The trend and outlook of Asia Pacific market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19. The balanced (most likely) projection is used to quantify Asia Pacific sports medicine market in every aspect of the classification from perspectives of Product, Application, End User, and Country.
Based on Product, the Asia Pacific market is segmented into the following sub-markets with annual revenue for 2019-2030 included in each section.
Body Reconstruction and Repair Devices
鈥 Fracture and Ligament Repair Devices
鈥 Implants
鈥 Arthroscopy Devices
鈥 Repair Devices
鈥 Orthobiologics
鈥 Prosthetics
Body Support and Recovery Devices
鈥 Braces and Supports
鈥 Physiotherapy
鈥 Compression Clothing
鈥 Topical Pain Relief
鈥 Other Body Support and Recovery Devices
Body Monitoring and Evaluation Devices
鈥 Cardiac Monitoring Devices
鈥 Respiratory Monitoring Devices
鈥 Hemodynamic Monitoring Devices
鈥 Musculoskeletal Monitoring Devices
鈥 Other Monitoring/Evaluation Devices
Accessories
Based on Application, the Asia Pacific market is segmented into the following sub-markets with annual revenue for 2019-2030 included in each section.
Knee Injury
鈥 Orthobiologic Devices
鈥 Suture Anchors
鈥 Meniscal Repair
鈥 Arthroscopy Devices
鈥 Fixation Devices
鈥 Ligament Reconstruction Systems
鈥 Other Knee Injury Devices
Shoulder Injury
鈥 Suture Anchors and Management System
鈥 Arthroscopy Devices
鈥 Orthobiologic & Biologic Implant
鈥 Other Shoulder Injury Products
Hip Injury
鈥 Suture Anchor and Management Systems
鈥 Arthroscopy Devices
鈥 Other Hip Injury Products
Foot and Ankle Injury
鈥 Implants and Screws
鈥 Fixation Systems
鈥 Orthobiologic Devices
Elbow and Wrist Injury
鈥 Implants and Screws
鈥 Orthobiologic Devices
Other Injuries
Based on End User, the Asia Pacific market is segmented into the following sub-markets with annual revenue for 2019-2030 included in each section.
鈥 Hospitals
鈥 Ambulatory Surgery Centers
鈥 Physiotherapy Centers and Clinics
鈥 Other End Users
Geographically, the following national/local markets are fully investigated:
鈥 Japan
鈥 China
鈥 South Korea
鈥 Australia
鈥 India
鈥 Rest of APAC (further segmented into Malaysia, Singapore, Indonesia, Thailand, New Zealand, Vietnam, Taiwan, and Philippines)
For each key country, detailed analysis and data for annual revenue are available for 2019-2030. The breakdown of key national markets by Product, Application, and End User over the forecast years are also included.
The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players.
Specifically, potential risks associated with investing in Asia Pacific sports medicine market are assayed quantitatively and qualitatively through GMD鈥檚 Risk Assessment System. According to the risk analysis and evaluation, Critical Success Factors (CSFs) are generated as a guidance to help investors & stockholders identify emerging opportunities, manage and minimize the risks, develop appropriate business models, and make wise strategies and decisions.
Key Players (this may not be a complete list and extra companies can be added upon request):
Arthrex Inc.
Bioventus LLC
Breg, Inc.
Ceterix Orthopaedics Inc.
ConMed Corporation
DJO, LLC
Johnson & Johnson
Mueller Sports Medicine, Inc.
Osiris Therapeutics, Inc.
RTI Surgical, INC.
Smith & Nephew plc
Stryker Corporation
Wright Medical Group N.V.
Zimmer Biomet Holdings Inc.
(Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)
Table of Contents
1 Introduction 7
1.1 Industry Definition and Research Scope 7
1.1.1 Industry Definition 7
1.1.2 Research Scope 8
1.2 Research Methodology 11
1.2.1 Overview of 麻豆原创 Research Methodology 11
1.2.2 麻豆原创 Assumption 12
1.2.3 Secondary Data 12
1.2.4 Primary Data 12
1.2.5 Data Filtration and Model Design 14
1.2.6 麻豆原创 Size/Share Estimation 15
1.2.7 Research Limitations 16
1.3 Executive Summary 17
2 麻豆原创 Overview and Dynamics 19
2.1 麻豆原创 Size and Forecast 19
2.1.1 Impact of COVID-19 on World Economy 20
2.1.2 Impact of COVID-19 on the 麻豆原创 23
2.2 Major Growth Drivers 25
2.3 麻豆原创 Restraints and Challenges 28
2.4 Emerging Opportunities and 麻豆原创 Trends 31
2.5 Porter鈥檚 Fiver Forces Analysis 35
3 Segmentation of Asia Pacific 麻豆原创 by Product 39
3.1 麻豆原创 Overview by Product 39
3.2 Body Reconstruction and Repair Devices 41
3.2.1 Fracture and Ligament Repair Devices 43
3.2.2 Implants 44
3.2.3 Arthroscopy Devices 45
3.2.4 Repair Devices 46
3.2.5 Orthobiologics 47
3.2.6 Prosthetics 48
3.3 Body Support and Recovery Devices 49
3.3.1 Braces and Supports 51
3.3.2 Physiotherapy 52
3.3.3 Compression Clothing 53
3.3.4 Topical Pain Relief 54
3.3.5 Other Body Support and Recovery Devices 55
3.4 Body Monitoring and Evaluation Devices 56
3.4.1 Cardiac Monitoring Devices 58
3.4.2 Respiratory Monitoring Devices 59
3.4.3 Hemodynamic Monitoring Devices 60
3.4.4 Musculoskeletal Monitoring Devices 61
3.4.5 Other Monitoring/Evaluation Devices 62
3.5 Accessories 63
4 Segmentation of Asia Pacific 麻豆原创 by Application 64
4.1 麻豆原创 Overview by Application 64
4.2 Knee Injury 66
4.3 Shoulder Injury 68
4.4 Hip Injury 70
4.5 Foot and Ankle Injury 72
4.6 Elbow and Wrist Injury 74
4.7 Other Injuries 76
5 Segmentation of Asia Pacific 麻豆原创 by End User 77
5.1 麻豆原创 Overview by End User 77
5.2 Hospitals 79
5.3 Ambulatory Surgery Centers 80
5.4 Physiotherapy Centers and Clinics 81
5.5 Other End Users 82
6 Asia-Pacific 麻豆原创 2019-2030 by Country 83
6.1 Overview of Asia-Pacific 麻豆原创 83
6.2 Japan 86
6.3 China 89
6.4 Australia 91
6.5 India 93
6.6 South Korea 95
6.7 Rest of APAC Region 97
7 Competitive Landscape 99
7.1 Overview of Key Vendors 99
7.2 New Product Launch, Partnership, Investment, and M&A 103
7.3 Company Profiles 104
Arthrex Inc. 104
Bioventus LLC 106
Breg, Inc. 107
Ceterix Orthopaedics Inc. 108
ConMed Corporation 109
DJO, LLC 110
Johnson & Johnson 111
Mueller Sports Medicine, Inc. 112
Osiris Therapeutics, Inc. 113
RTI Surgical, INC. 114
Smith & Nephew plc 115
Stryker Corporation 116
Wright Medical Group N.V. 117
Zimmer Biomet Holdings Inc. 118
8 Investing in Asia Pacific 麻豆原创: Risk Assessment and Management 119
8.1 Risk Evaluation of Asia Pacific 麻豆原创 119
8.2 Critical Success Factors (CSFs) 122
Related Reports and Products 125
Key Players (this may not be a complete list and extra companies can be added upon request):
Arthrex Inc.
Bioventus LLC
Breg, Inc.
Ceterix Orthopaedics Inc.
ConMed Corporation
DJO, LLC
Johnson & Johnson
Mueller Sports Medicine, Inc.
Osiris Therapeutics, Inc.
RTI Surgical, INC.
Smith & Nephew plc
Stryker Corporation
Wright Medical Group N.V.
Zimmer Biomet Holdings Inc.
听
听
*If Applicable.